Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind placebo-controlled trial of Keming Capsule for post-infectious cough (yang deficiency and cold invading lung pattern)
CTR20240031Phase 3Completed
- Sponsor
- Jinan Kangzhong Pharmaceutical Technology Development
- Start
- Jan 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Keming Capsule in postinfectious cough, sponsored by Jinan Kangzhong Pharmaceutical Technology Development. Started Jan 2025; status: completed.
02
Drugs
Keming Capsule
03
Conditions
postinfectious cough
Beyond the preview
Go deeper on CTR20240031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240031.